Dyne Therapeutics (DYN) had the highest return on January 4, 2024 by a small-cap US stock, returning 34.9%.

ASSET	DATE	% RETURN
Dyne Therapeutics (DYN)	1/4/2024	34.93%
Advent Technologies (ADNWW)	1/4/2024	28.8%
Innoviz Technologies (INVZW)	1/4/2024	23.69%
ADC Therapeutics (ADCT)	1/4/2024	22.08%
Katapult Holdings Equity Warrants Exp 09 June 2026 (KPLTW)	1/4/2024	20.51%
Aeluma (ALMU)	1/4/2024	19.6%
Altimmune (ALT)	1/4/2024	17.78%
Airnet Technology (ANTE)	1/4/2024	16.25%
Praxis Precision Medicines (PRAX)	1/4/2024	14.24%
Akso Health Group ADR (AHG)	1/4/2024	13.75%
PepGen (PEPG)	1/4/2024	12.82%
Barnes & Noble Education (BNED)	1/4/2024	11.69%
Ramaco Resources (METC)	1/4/2024	10.25%
Akebia Ther (AKBA)	1/4/2024	10.14%
Select Medical (SEM)	1/4/2024	9.97%
Corvus Pharmaceuticals (CRVS)	1/4/2024	9.9%
flyExclusive (FLYX)	1/4/2024	9.66%
Lifeway Foods (LWAY)	1/4/2024	9.28%
Nutex Health (NUTX)	1/4/2024	9.25%
Alliance Entertainment Holding Corporation Class A Common Stock (AENT)	1/4/2024	8.51%
Real Brokerage (REAX)	1/4/2024	8.48%
Solid Power (SLDP)	1/4/2024	8.4%
Northern Dynasty Minerals (NAK)	1/4/2024	8.31%
Aquestive Therapeutics (AQST)	1/4/2024	8.13%
Kopin (KOPN)	1/4/2024	8.12%

Small-cap stocks are treated as having a market cap between $300M and $2B.